Skip to main content
. 2024 Dec 16;15:1494772. doi: 10.3389/fmicb.2024.1494772

Table 2.

Effect of 32 and 64 mg/L RV in presence or absence of CHX and BZK sub-MIC concentrations, alone or in combination, on biofilm formation in A. baumannii ATCC 19606 and isogenic mutants of AmvA, AdeB, AdeJ, AceI EPs.

Strains
Treatment ATCC 19606 ∆adeB ∆adeJ ∆aceI ∆amvA
TSB 1.02 ± 0.05 0.59 ± 0.03 0.54 ± 0.01 0.76 ± 0.06 0.57 ± 0.06
32 RV 0.74 ± 0.06 0.54 ± 0.06 0.63 ± 0.03 0.78 ± 0.01 0.69 ± 0.06
0 RV 1/8 CHX MIC 0.99 ± 0.01 0.52 ± 0.01 0.61 ± 0.03 0.71 ± 0.03 0.50 ± 0.03
1/4 CHX MIC 0.98 ± 0.03 0.49 ± 0.01 0.55 ± 0.03 0.61 ± 0.04 0.50 ± 0.01
1/2 CHX MIC 0.87 ± 0.08 0.47 ± 0.02 0.53 ± 0.03 0.54 ± 0.03 0.53 ± 0.04
1/8 BZK MIC 0.74 ± 0.01 0.54 ± 0.06 0.54 ± 0.03 0.77 ± 0.04 0.34 ± 0.04
1/4 BZK MIC 0.64 ± 0.1* 0 ± 0.02*** 0.21 ± 0.03** 0.59 ± 0.04 0.34 ± 0.01
1/2 BZK MIC 0.67 ± 0.04* 0 ± 0.02*** 0 ± 0.02*** 0.61 ± 0.04 0.35 ± 0.01
1/8 CHX MIC+1/8 BZK MIC 0.73 ± 0.01 0.53 ± 0.01 0 ± 0.1*** 0.64 ± 0.03 0.45 ± 0.01
1/4 CHX MIC+1/4 BZK MIC 0.5 ± 0.03** 0 ± 0.02*** 0 ± 0.03*** 0.19 ± 0.06*** 0.42 ± 0.06
½ CHX MIC+ ½ BZK MIC 0.41 ± 0.03** 0 ± 0.1*** 0 ± 0.1*** 0 ± 0.03*** 0 ± 0.03***
32 RV 1/8 CHX MIC 0.75 ± 0.01 0.5 ± 0.02 0.60 ± 0.04 0.42 ± 0.03* 0.52 ± 0.04
1/4 CHX MIC 0.70 ± 0.04 0.49 ± 0.02 0.51 ± 0.04 0.45 ± 0.03* 0.50 ± 0.01
1/2 CHX MIC 0.73 ± 0.04 0 ± 0.04*** 0.42 ± 0.01 0.41 ± 0.01* 0.42 ± 0.01
1/8 BZK MIC 0.71 ± 0.0* 0.55 ± 0.02 0.59 ± 0.06 0.70 ± 0.04 0.45 ± 0.01
1/4 BZK MIC 0.64 ± 0.03* 0 ± 0.02*** 0 ± 0.02*** 0.62 ± 0.01 0.44 ± 0.03
1/2 BZK MIC 0.67 ± 0.02* 0 ± 0.1*** 0 ± 0.01*** 0.40 ± 0.04* 0.43 ± 0.01
1/8 CHX MIC+1/8 BZK MIC 0.44 ± 0.02** 0 ± 0.02*** 0 ± 0.04*** 0.52 ± 0.03 0.54 ± 0.04
1/4 CHX MIC+1/4 BZK MIC 0 ± 0.02*** 0 ± 0.1*** 0 ± 0.01*** 0.0 ± 0.01*** 0.0 ± 0.03***
1/2 CHX MIC+1/2 BZK MIC 0 ± 0.02*** 0 ± 0.03*** 0 ± 0.03*** 0 ± 0.03*** 0 ± 0.03***

The results are shown as OD595 nm/600 nm; Synergistic inhibitory effects of RV and/or CHX and BZK on biofilm formation are shown in bold; p-values were calculated using two-way ANOVA (*p < 0.05; **p < 0.01; ***p < 0.001). Assays were performed in triplicate.